Announcements Trials
Browse Landscape

Phase

Phase 2 1

Status

Completed 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Other hematologic neoplasm 1Myeloid 1Lymphoid 1Gynecologic 1

Conditions

Leukemia 2Vitamin D Deficiency 1Precursor Cell Lymphoblastic Leukemia-Lymphoma 1Ovarian Neoplasms 1Osteoporosis 1Obesity 1Myelodysplastic Syndromes 1Lymphoma 1

Interventions

Cyclophosphamide 4sargramostim 3Psychiatric Rehabilitation 3Paclitaxel 3Flow Cytometry 3trametinib 2pertuzumab 2pembrolizumab 2dabrafenib 2Trastuzumab 2Specimen Handling 2Palliative Care 2Methylprednisolone 2Melphalan 2Magnetic Resonance Spectroscopy 2Immunologic Techniques 2Filgrastim 2Biopsy 2Azacitidine 2Analgesia 2Amifostine 2Alemtuzumab 2varlilumab 1ulixertinib 1trastuzumab biosimilar HLX02 1tanespimycin 1stenoparib 1sapanisertib 1ruxolitinib 1rucaparib 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Ovarian Neoplasms × Calcium Citrate × Other hematologic neoplasm × Clear all
NCT00321932 2017-03-09

Zoledronic Acid in Preventing Osteoporosis in Patients Undergoing Donor Stem Cell Transplant

University of Minnesota

Phase 2 Completed
61 enrolled 16 charts
GynecologicLymphoidMyeloidOther hematologic neoplasm

Leukemia, Lymphoma, Myelodysplastic Syndromes, Osteoporosis, Ovarian Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡